Safety Profile of Infinity Deep Brain Stimulation Electrode Placement in a 1.5T Interventional MRI Suite: Consecutive Single-Institution Case Series

References

1. 1.↵
   1. Lee DJ,
   2. Lozano CS,
   3. Dallapiazza RF, et al

   . Current and future directions of deep brain stimulation for neurological and psychiatric disorders. J Neurosurg 2019;131:333–42 doi:10.3171/2019.4.JNS181761 pmid:31370011

   CrossRefPubMed
2. 2.↵
   1. Ostrem JL,
   2. Galifianakis NB,
   3. Markun LC, et al

   . Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg 2013;115:708–12 doi:10.1016/j.clineuro.2012.08.019 pmid:22944465

   CrossRefPubMed
3. 3.↵
   1. Ostrem JL,
   2. Ziman N,
   3. Galifianakis NB, et al

   . Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease. J Neurosurg 2016;124:908–16 doi:10.3171/2015.4.JNS15173 pmid:26495947

   CrossRefPubMed
4. 4.↵
   1. Martin AJ,
   2. Larson PS,
   3. Ziman N, et al

   . Deep brain stimulator implantation in a diagnostic MRI suite: infection history over a 10-year period. J Neurosurg 2017;126:108–13 doi:10.3171/2015.7.JNS15750 pmid:27015399

   CrossRefPubMed
5. 5.↵
   1. Martin AJ,
   2. Starr PA,
   3. Ostrem JL, et al

   . Hemorrhage detection and incidence during magnetic resonance-guided deep brain stimulator implantations. Stereotact Funct Neurosurg 2017;95:307–14 doi:10.1159/000479287 pmid:28889128

   CrossRefPubMed
6. 6.↵
   ClinicalTrials.gov. MRI study of Infinity DBS System. ClinicalTrials.gov Identifier: NCT03884231. https://clinicaltrials.gov/ct2/show/NCT03884231. Accessed April 17, 2020
7. 7.↵
   1. Agha RA,
   2. Borrelli MR,
   3. Farwana R

   , PROCESS Group, et al. The PROCESS 2018 statement: updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) guidelines. Int J Surg Lond Surg 2018;60:279–82 doi:10.1016/j.ijsu.2018.10.031 pmid:30359781

   CrossRefPubMed
8. 8.↵
   1. Starr PA,
   2. Markun LC,
   3. Larson PS, et al

   . Interventional MRI-guided deep brain stimulation in pediatric dystonia: first experience with the ClearPoint system. J Neurosurg Pediatr 2014;14:400–08 doi:10.3171/2014.6.PEDS13605 pmid:25084088

   CrossRefPubMed
9. 9.↵
   St. Jude Medical. MRI Procedure Information For St. Jude Medical^TM MR Conditional Deep Brain Stimulation Systems. St. Jude Medical; 2018
10. 10.↵
    1. Faulkner W

    . B1+rms as a condition of use. Signals 2016;5. https://www.ismrm.org/smrt/E-Signals/2016FEBRUARY/eSig_5_1_hot_2.htm. Accessed August 18, 2020
11. 11.↵
    1. Hiss S,
    2. Hesselmann V,
    3. Hunsche S, et al

    . Intraoperative functional magnetic resonance imaging for monitoring the effect of deep brain stimulation in patients with obsessive-compulsive disorder. Stereotact Funct Neurosurg 2015;93:30–37 doi:10.1159/000368805 pmid:25661910

    CrossRefPubMed
12. 12.↵
    1. In M-H,
    2. Cho S,
    3. Shu Y, et al

    . Correction of metal-induced susceptibility artifacts for functional MRI during deep brain stimulation. NeuroImage 2017;158:26–36 doi:10.1016/j.neuroimage.2017.06.069 pmid:28666879

    CrossRefPubMed